Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Physiol Pharmacol ; 74(5)2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-38085518

RESUMEN

Spent hops extract (SHE) is a plant extract containing compounds with proven anti-inflammatory and anti-angiogenic activities. However, extract may exert synergic effects compared to its individual polyphenol components. Inflammatory diseases of the retina may lead to visual impairment, a reduction of the comfort of life, and even blindness due to the formation of new pathological blood vessels. More effective therapeutic options are being sought. The goal of the present study was to investigate the anti-inflammatory and anti-angiogenic potentials of SHE on human retinal pigment epithelial cells (ARPE-19) stimulated by lipopolysaccharide (LPS) or tumor necrosis factor alpha (TNF-α). The SHE (250 µg/mL) was found to downregulate the gene expression of interleukin 6 (IL-6) to 33% in LPS-triggered cells; it also reduced both matrix metalloproteinase 2 (MMP-2) and 9 (MMP-9) mRNA expression to 13% and 43% respectively, and their activity to 82% (MMP-2) and 57% (MMP-9), compared to TNF-α-stimulated cells. Also, SHE modulated the TNF-α-induced expression of vascular endothelial growth factor (VEGF) and endothelial growth factor receptor 2 (VEGFR2). It is possible that SHE inhibited retinal inflammation and angiogenesis by suppressing the nuclear factor kappa B (NF-κB), protein kinase B (Akt) and extracellular signal-regulated kinase (ERK) pathways. Our results demonstrate that SHE has anti-inflammatory and anti-angiogenic potential against retinal diseases. This is the first such study to report on the efficacy of SHE on retinal inflammatory diseases.


Asunto(s)
Humulus , FN-kappa B , Humanos , FN-kappa B/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Metaloproteinasa 2 de la Matriz , Humulus/metabolismo , Metaloproteinasa 9 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Lipopolisacáridos/farmacología , Angiogénesis , China , Etnicidad , Retina , Inflamación/tratamiento farmacológico , Antiinflamatorios/farmacología , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
2.
J Physiol Pharmacol ; 73(3)2022 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36515626

RESUMEN

There is a great deal of interest in identifying new chemopreventive agents for colorectal cancer, one of the leading causes of cancer-related death. One promising group of candidates is the polyphenols; being natural compounds with high structural diversity, they have a very wide spectrum of anti-inflammatory, anti-oxidant and anti-cancer properties. The present study reports for the first time that spent hops extract (SHE) inhibits the angiogenesis, invasion and migration of SW-480 and HT-29 colorectal adenocarcinoma cells; after incubation with 200 µg/mL SHE, SW-480 and HT-29 cell invasion fell by 98.5% and 89% vs. controls, and migration was inhibited by 99% and 88% vs. controls. These changes were accompanied by a decline of matrix metalloproteinase 2 (MMP-2) and MMP-9 expression and activity. In addition, SHE reduced the expression of vascular endothelial growth factor and hypoxia-inducible factor 1α for both cell lines, indicating that the tested extract has anti-angiogenic potential. In conclusion, our data shows that SHE may be an effective chemopreventive agent acting via the inhibition of angiogenesis, invasion and migration of colorectal cancer cells.


Asunto(s)
Neoplasias Colorrectales , Humulus , Humanos , Humulus/química , Humulus/metabolismo , Metaloproteinasa 2 de la Matriz , Factor A de Crecimiento Endotelial Vascular/metabolismo , Extractos Vegetales/farmacología , Antioxidantes/farmacología , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/prevención & control , Movimiento Celular , Línea Celular Tumoral
3.
J Physiol Pharmacol ; 73(2)2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35988931

RESUMEN

The objective of this study was to investigate the phytochemical composition, antioxidant and cytotoxic potential of aronia leaf crude phenolic-extract (ACE) and purified phenolic-rich extract (APE) on human intestinal cells (CCD 841 CoN) and colon cancer cells (SW-480 and HT-29). UPLC-Q-TOF-MS analysis confirmed that aronia leaves are rich in structurally diverse polyphenols (25 and 42 compounds for ACE and APE, respectively). Chlorogenic acid and quercetin-3-rutinoside were most abundant in both aronia extracts. The sum of detected polyphenols varied significantly between extracts ranging from 32.8 mg/g (ACE) to 436.3 mg/g (APE). The biological potential of aronia extracts was confirmed by applying in vitro antioxidant and cytotoxic assays. The results of antioxidant activity (ABTS and FRAP) indicate that APE showed 2-fold stronger antioxidant properties compared to ACE. APE revealed a stronger cytotoxic effect on SW-480 and HT-29 cells than ACE (MTT test). After 48 -hours of incubation, APE was found to inhibit SW-480 cell growth by 50% vs. control at 194.35 µg/mL, while for HT-29 cells it was observed at 552.02 µg/mL. In the case of ACE, IC50 has not been reached for SW-480 cells after 48 -hours of treatment, but for HT-29 it was 794.84 µg/mL. Moreover, the viability was significantly decreased in a concentration- and time-dependent manner for both cancer cell lines. Examined extracts showed selective inhibitory potential against colon cancer cells. However, after 72 h incubation with CCD 841 CoN cells, the obtained IC50 values for APE and ACE were 594 µg/mL and 709 µg/mL respectively. This suggests that aronia leaves are valuable natural-based products that may support the treatment as chemopreventive agents in colorectal cancer.


Asunto(s)
Antineoplásicos , Neoplasias del Colon , Photinia , Antioxidantes/química , Antioxidantes/farmacología , Neoplasias del Colon/tratamiento farmacológico , Humanos , Fenoles/farmacología , Photinia/química , Extractos Vegetales/química , Extractos Vegetales/farmacología
4.
J Physiol Pharmacol ; 73(1)2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-35639036

RESUMEN

Japanese quince leaf phenol-rich extract (PRE) represents a good source of phenolic compounds, among which chlorogenic acid and naringenin hexoside are the main constituents. The aim of this research was to evaluate the chemopreventive activity of PRE in human colon cancer (SW-480 and HT-29) and human normal colon cell line (CCD 841 CoN). All cell lines were exposed to different concentrations of the extract (150-500 κg/mL for SW-480 and CCD 841 CoN; and 250-750 κg/mL for HT-29) to investigate migration and invasion, as well as the activity and secretion of metalloproteinases (MMP-2 and MMP-9) involved in these mechanisms. Moreover, the influence of PRE on the activity of ERK and AKT pathways, which are strongly involved in colon cancer development (CRC), were measured. Our results demonstrated that PRE significantly inhibited migration and invasion in SW-480, HT-29 and CCD 841 CoN cells through MMP-2 and MMP-9-dependent mechanisms. We also proved that PRE can effectively downregulate both the activity and protein expression of MMP-2 and MMP-9 in these cell lines. The exception was the higher concentration of PRE, which up-regulated the protein expression of MMP-9 in SW-480. Additionally, we showed that significant inhibition of p-ERK/p-AKT expression in SW-480 after treatment with PRE is involved in chemopreventive effects of this extract. In case of exposure of HT-29 cells to PRE, we observed a significant upregulation of p-ERK protein expression, and suppression of p-AKT mechanism. This research of Japanese quince phenol leaf extract suggests its application in colon cancer prevention and treatment due to its ability to inhibit migration and invasion in MMP-9 and MMP-2-dependent mechanisms via most likely the modulation of ERK and AKT signaling pathways in colon cancer cells. Overall, our results provide an experimental foundation for further research on its potential activities and effects in vivo.


Asunto(s)
Neoplasias del Colon , Rosaceae , Neoplasias del Colon/tratamiento farmacológico , Neoplasias del Colon/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Humanos , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Fenol , Fenoles/farmacología , Extractos Vegetales/farmacología , Proteínas Proto-Oncogénicas c-akt/metabolismo , Transducción de Señal
5.
J Physiol Pharmacol ; 71(2)2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-32633239

RESUMEN

Phenolic compounds are very important in the prevention and treatment of many civilization diseases, including colorectal cancer (CRC). In the present study we investigated and compared the phytochemical composition, antioxidant and cytotoxic activity of Japanese quince (Chaenomeles japonica L.) leaves crude phenolic extract (CPE) and purified phenolic-rich extracts (PRE). The UPLC-Q-TOF-MS analysis showed that both extracts contain diversified phenolics compounds (33 - 36 compounds in the PRE and CPE, respectively), among which chlorogenic acid and naringenin hexoside turned out to be the main constituents. Both FRAP and ABTS tests showed that PRE had 2-fold higher antioxidant activity compared to CPE. Furthermore, PRE exhibited a higher cytotoxic activity towards colon cancer cells (SW-480 and HT-29) than CPE. After 24-hours incubation with PRE the IC50 value for SW-480 cell line was obtained at the concentration of 239 µg/mL, while CPE treatment caused the same decrease only after 72h at 277 µg/mL. In addition, PRE had a stronger cytotoxic effect on the colon cancer cell lines (SW-480 and HT-29) than on normal intestinal cells (CCD-18Co and CCD 841 CoN). These results provide the first evidence that extracts from Japanese quince leaves (especially phenolic-rich extract, PRE) strongly decrease the viability of both SW-480 and HT-29 lines, which may suggest their cytotoxic activity towards colon cancer cells.


Asunto(s)
Neoplasias del Colon/tratamiento farmacológico , Fenoles/farmacología , Rosaceae/química , Antineoplásicos/farmacología , Antioxidantes/aislamiento & purificación , Antioxidantes/fisiología , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Neoplasias del Colon/metabolismo , Humanos , Fenoles/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Hojas de la Planta/química
6.
J Physiol Pharmacol ; 71(1)2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-32350150

RESUMEN

Macrophages play important roles in acute and chronic inflammation. Upon their activation, they secrete a variety of mediators, including eicosanoids, nitric oxide and cytokines, which play different roles in the stimulation and resolution of inflammatory processes. There is a continuous search for selective modulators of these processes. Natural polyphenols and polyphenol-rich extracts have been found to possess preventive and therapeutic potential, including by their anti-inflammatory effects. In this study, the inhibition of the formation of inflammatory mediators by the spent hops extract (SHE), a polyphenol-rich extract from Humulus Lupulus L., was examined using lipopolysaccharide (LPS)- activated murine macrophages (RAW 264.7). The SHE suppressed inter alia the interleukin-6 (IL-6) mRNA expression to 32% in LPS-activated macrophages and to 61% at a protein level (at 25 µg/mL). SHE reduced both the cyclooxygenase-2 (COX-2) mRNA expression to 47% and their protein expression to 32%. Not only did SHE inhibit the IL-6 and COX-2 levels but also decreased both inducible nitric oxide synthase (iNOS) protein expression to 2% at 25 µg/mL and nitric oxide (NO) production for all tested concentrations. The inhibited expression of these inflammatory molecules was likely caused by the reduced activity of nuclear factor-κB (NF-κB). Both mRNA and protein expression of NF-κB was decreased to 38% and 42%, respectively. These results provide the first evidence that SHE decreases the expression of proinflammatory cytokines and inflammatory mediators, which merits further studies to investigate the potential of SHE as anti-inflammatory preparation.


Asunto(s)
Humulus , Mediadores de Inflamación/antagonistas & inhibidores , Mediadores de Inflamación/metabolismo , Lipopolisacáridos/toxicidad , Macrófagos/metabolismo , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/fisiología , Relación Dosis-Respuesta a Droga , Macrófagos/efectos de los fármacos , Ratones , Extractos Vegetales/aislamiento & purificación , Células RAW 264.7
7.
J Physiol Pharmacol ; 71(6)2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-33727430

RESUMEN

In the present study we investigated the anti-inflammatory activity of Japanese quince leaf polyphenol-rich extract (JQLPE) in lipopolysaccharide (LPS)-activated murine macrophages (RAW 264.7). The Q-PCR analysis revealed that JQLPE decreased Nfkb1, Ptgs2, and Il1b expression at the mRNA level by 80%, 50% and 48%, respectively. Similarly, JQLPE significantly attenuated expression of inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2), interleukin-1beta (IL-1ß), IL-6 and tumor necrosis factor alpha (TNF-α) (by 60%, 50%, 67%, 37% and 36%, respectively) at the protein level and nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated RAW264.7. Western blot also showed that the expression of nuclear factor kappaB (NF-κB) p65 and p-NF-κB p65 was down-regulated after JQLPE treatment. These results provide the first evidence that JQLPE decreases the expression of pro-inflammatory cytokines (IL-1ß, IL-6, TNF-α), inflammatory mediators (COX-2, iNOS) and both NF-κB p65 and p-NF-κB p65 in LPS-stimulated RAW264.7 cells, which may suggest its anti-inflammatory activity.


Asunto(s)
Antiinflamatorios/farmacología , Macrófagos/efectos de los fármacos , Extractos Vegetales/farmacología , Rosaceae/química , Animales , Antiinflamatorios/aislamiento & purificación , Inflamación/tratamiento farmacológico , Mediadores de Inflamación/metabolismo , Lipopolisacáridos , Macrófagos/patología , Ratones , Óxido Nítrico/metabolismo , Fenol/química , Hojas de la Planta , Células RAW 264.7
8.
Naunyn Schmiedebergs Arch Pharmacol ; 387(11): 1069-78, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25079872

RESUMEN

Oenothera paradoxa (EP) preparations are commonly used in folk medicine to treat skin diseases, neuralgia, and gastrointestinal (GI) disorders. Several reports suggested that EP preparations exhibit potent anti-inflammatory and antioxidant activities both in vitro and in vivo. Here, we aimed to characterize the action of EP pomace polyphenol extract in mouse model of colitis. We analyzed the composition of EP pomace polyphenol extract using reversed phase HPLC system and ultra-performance liquid chromatography (UPLC) system coupled with a quadrupole-time of flight (Q-TOF) MS instrument. Then, we used a well-established animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis to determine the anti-inflammatory action of EP pomace polyphenol extract. We also investigated the effect of the EP pomace polyphenol extract on pro-inflammatory (IL-1ß and TNF-α) cytokine mRNA levels and hydrogen peroxide concentration in the inflamed colon. Administration of EP pomace polyphenol extract significantly improved macroscopic and microscopic damage scores, as well as myeloperoxidase (MPO) activity in TNBS-treated mice. The anti-inflammatory effect of the extract was observed after intracolonic and oral administration and was dose-dependent. Significant reduction of tissue hydrogen peroxide level after treatment with EP pomace polyphenol extract suggests that its therapeutic effect is a result of free radical scavenging. This novel finding indicates that the application of the EP pomace polyphenol extract in patients with inflammatory bowel diseases (IBDs) may become an attractive supplementary treatment for conventional anti-inflammatory therapy.


Asunto(s)
Colitis/tratamiento farmacológico , Oenothera biennis/química , Extractos Vegetales/farmacología , Polifenoles/farmacología , Administración Oral , Animales , Antiinflamatorios/administración & dosificación , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Cromatografía Líquida de Alta Presión , Colitis/fisiopatología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Depuradores de Radicales Libres/administración & dosificación , Depuradores de Radicales Libres/aislamiento & purificación , Peróxido de Hidrógeno/metabolismo , Interleucina-1beta/genética , Masculino , Espectrometría de Masas , Ratones , Ratones Endogámicos C57BL , Extractos Vegetales/administración & dosificación , Polifenoles/administración & dosificación , Polifenoles/aislamiento & purificación , Ácido Trinitrobencenosulfónico/toxicidad , Factor de Necrosis Tumoral alfa/genética
9.
Appl Environ Microbiol ; 69(8): 4788-93, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12902272

RESUMEN

Potato cyst nematodes (PCN) are serious pests in commercial potato production, causing yield losses valued at approximately $300 million in the European Community. The nematophagous fungus Plectosphaerella cucumerina has demonstrated its potential as a biological control agent against PCN populations by reducing field populations by up to 60% in trials. The use of biological control agents in the field requires the development of specific techniques to monitor the release, population size, spread or decline, and pathogenicity against its host. A range of methods have therefore been developed to monitor P. cucumerina. A species-specific PCR primer set (PcCF1-PcCR1) was designed that was able to detect the presence of P. cucumerina in soil, root, and nematode samples. PCR was combined with a bait method to identify P. cucumerina from infected nematode eggs, confirming the parasitic ability of the fungus. A selective medium was adapted to isolate the fungus from root and soil samples and was used to quantify the fungus from field sites. A second P. cucumerina-specific primer set (PcRTF1-PcRTR1) and a Taqman probe (PcRTP1) were designed for real-time PCR quantification of the fungus and provided a very sensitive means of detecting the fungus from soil. PCR, bait, and culture methods were combined to investigate the presence and abundance of P. cucumerina from two field sites in the United Kingdom where PCN populations were naturally declining. All methods enabled differences in the activity of P. cucumerina to be detected, and the results demonstrated the importance of using a combination of methods to investigate population size and activity of fungi.


Asunto(s)
Nematodos/crecimiento & desarrollo , Control Biológico de Vectores , Phyllachorales/aislamiento & purificación , Reacción en Cadena de la Polimerasa/métodos , Solanum tuberosum/parasitología , Animales , Medios de Cultivo , Raíces de Plantas/microbiología , Microbiología del Suelo , Solanum tuberosum/microbiología
10.
Clin Exp Immunol ; 116(2): 270-5, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10337018

RESUMEN

Murine peritoneal macrophages, elicited with thioglycollate, were stimulated in vitro with lipopolysaccharide (LPS). The production of nitrite, superoxide anion (SOA), and the accumulation of nitrotyrosine in the cells increased after treatment, and all were inhibitable by the NO synthase inhibitor NG-monomethyl-L-arginine monoacetate (L-NMMA). This effect suggests a direct correlation between the accumulation of those metabolites and NO synthase activity. Lipoarabinomannan (LAM) purified from Mycobacterium tuberculosis was added to peritoneal macrophages in the presence of interferon-gamma (IFN-gamma); the cells produced nitrite and SOA, both inhibitable by L-NMMA. There was, as well, accumulation of nitrotyrosine in the macrophage proteins. Strikingly, the amount of nitrotyrosine measured after LAM plus IFN-gamma, or LAM plus the low molecular weight adjuvant glutamylmuramyl dipeptide (GMDP), increased significantly in the presence of L-NMMA. These results suggest that murine macrophages, upon LAM stimulation, might generate reactive nitrogen metabolites by a route other than NO synthase. Nitrotyrosine accumulation after infection of macrophages in vitro, with either live bacille Calmette-Guérin (BCG) or live M. tuberculosis, in the presence or absence of IFN-gamma, showed no correlation with nitrite production, suggesting a low superoxide production.


Asunto(s)
Lipopolisacáridos/farmacología , Macrófagos/metabolismo , Mycobacterium tuberculosis/fisiología , Tirosina/análogos & derivados , Animales , Femenino , Interferón gamma/farmacología , Activación de Macrófagos , Ratones , Ratones Endogámicos C57BL , Conejos , Especies Reactivas de Oxígeno , Tirosina/biosíntesis , omega-N-Metilarginina/farmacología
11.
Anticancer Res ; 18(1A): 441-3, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9568116

RESUMEN

The growth of solid tumors and their metastasis is dependent on the development of new blood vessels (angiogenesis). In this study, we examined the effect of the angiogenesis inhibitor TNP-470 on a fast growing melanoma in hamsters. The effect was observed both on tumor growth and metastasis. Treatment with TNP-470 caused a significant decrease in the rate of tumor growth and suppression of the development of metastasis in 63% of treated animals. Some of the hamsters treated with TNP-470 had the tumor excised and the effect of that operation on the development of metastasis was examined. In such cases the inhibitory effect of TNP-470 was weaker than in tumor bearing animals. This indicates that excision of tumor created more favourable conditions for angiogenesis and that the dose of TNP-470 should be increased to be effective in such conditions.


Asunto(s)
Antibióticos Antineoplásicos/uso terapéutico , Melanoma Experimental/tratamiento farmacológico , Neovascularización Patológica/prevención & control , Sesquiterpenos/uso terapéutico , Animales , Cricetinae , Ciclohexanos , Femenino , Masculino , Melanoma Experimental/patología , Mesocricetus , Metástasis de la Neoplasia , Trasplante de Neoplasias , O-(Cloroacetilcarbamoil) Fumagilol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA